Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. (SHE:301290)

SHE:301290 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	416.84	430.47	430.5	440.73	442.57	354.91
Other Revenue	4.99	4.99	3.23	1.37	3.93	19.52
Revenue	421.83	435.46	433.73	442.1	446.5	374.43
Revenue Growth (YoY)	-4.46%	0.40%	-1.89%	-0.98%	19.25%	26.67%
Cost of Revenue	216	221.08	225.86	210.6	195.33	167.82
Gross Profit	205.83	214.38	207.88	231.5	251.17	206.61
Selling, General & Admin	110.57	112.72	106.62	93.08	104.58	91.48
Research & Development	21.8	22.43	27.11	24.21	20.67	18.32
Other Operating Expenses	7.03	5.18	2.65	4.39	3.14	4.19
Operating Expenses	139.83	140.77	135.94	124.56	128.17	112.8
Operating Income	66	73.6	71.94	106.94	123	93.82
Interest Expense	-0.34	-0.34	-0.06	-0.13	-0.11	-2.3
Interest & Investment Income	33.8	39.4	16.25	5.28	2.4	1.18
Currency Exchange Gain (Loss)	-0.14	-0.14	-0.02	0.49	-0.1	-0.15
Other Non Operating Income (Expenses)	-1.46	-0.1	-0.05	-0.28	-0.34	-0.3
EBT Excluding Unusual Items	97.86	112.42	88.05	112.3	124.85	92.25
Gain (Loss) on Sale of Investments	-1.88	-7	13.69	0.5	-	-
Gain (Loss) on Sale of Assets	-0.05	-0.09	-0.59	-0.43	-0.25	-0.13
Asset Writedown	-0.06	-	-	-	-	-
Other Unusual Items	9.73	9.73	15.91	7.44	5.33	3.51
Pretax Income	105.6	115.06	117.06	119.82	129.93	95.63
Income Tax Expense	16.63	18.17	17.18	16.1	18.86	15.35
Earnings From Continuing Operations	88.97	96.89	99.88	103.72	111.07	80.28
Minority Interest in Earnings	0.63	0.53	-2.66	-1.21	-0.82	-0.57
Net Income	89.6	97.42	97.22	102.51	110.25	79.7
Net Income to Common	89.6	97.42	97.22	102.51	110.25	79.7
Net Income Growth	-9.61%	0.21%	-5.15%	-7.03%	38.33%	68.22%
Shares Outstanding (Basic)	100	99	100	77	75	68
Shares Outstanding (Diluted)	100	99	100	77	75	68
Shares Change (YoY)	-0.42%	-0.81%	30.05%	2.76%	10.45%	25.21%
EPS (Basic)	0.90	0.98	0.97	1.33	1.47	1.17
EPS (Diluted)	0.90	0.98	0.97	1.33	1.47	1.17
EPS Growth	-9.23%	1.03%	-27.07%	-9.52%	25.64%	34.48%
Free Cash Flow	22.26	10.54	51.68	20.28	67.78	88.64
Free Cash Flow Per Share	0.22	0.11	0.52	0.26	0.90	1.30
Dividend Per Share	0.600	0.600	0.600	0.500	-	-
Dividend Growth	-	-	20.00%	-	-	-
Gross Margin	48.80%	49.23%	47.93%	52.36%	56.25%	55.18%
Operating Margin	15.65%	16.90%	16.59%	24.19%	27.55%	25.06%
Profit Margin	21.24%	22.37%	22.41%	23.19%	24.69%	21.29%
Free Cash Flow Margin	5.28%	2.42%	11.91%	4.59%	15.18%	23.67%
EBITDA	108.73	115.31	109.58	141.18	150.64	117.07
EBITDA Margin	25.77%	26.48%	25.26%	31.93%	33.74%	31.27%
D&A For EBITDA	42.72	41.71	37.64	34.24	27.64	23.26
EBIT	66	73.6	71.94	106.94	123	93.82
EBIT Margin	15.65%	16.90%	16.59%	24.19%	27.55%	25.06%
Effective Tax Rate	15.75%	15.79%	14.68%	13.44%	14.52%	16.05%
Revenue as Reported	435.46	435.46	433.73	442.1	446.5	374.43
Advertising Expenses	-	2.07	1.87	1.34	2.48	1.85

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.